A Multicenter, Randomized, Double-Blind, Placebo Control Study of IN-105 tablets [oral insulin] in Patients with Type 2 Diabetes Mellitus who have inadequate Glycemic Control on Optimal doses of Extended Release Metformin Tablets.
Phase of Trial: Phase III
Latest Information Update: 26 Aug 2016
At a glance
- Drugs Insulin tregopil (Primary)
- Indications Type 2 diabetes mellitus
- Focus Registrational; Therapeutic Use
- Sponsors Biocon
- 01 Oct 2012 Status changed from active, no longer recruiting to completed as reported by Clinical Trials Registry - India.
- 15 Jun 2010 Status changed from recruiting to active, no longer recruiting as reported by Clinical Trials Registry - India record.
- 01 Jul 2009 New trial record